{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:30Z","timestamp":1790946690597,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0069293","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T22:30:29Z","timestamp":1374791429000},"page":"e69293","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"S\u00e9verine","family":"Lecourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enguerran","family":"Mouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Freida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Cras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Ceccaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djazia","family":"Heraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chomienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Marolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vanneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Belmatoug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Larghero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher&apos;s disease","volume":"372","author":"GA Grabowski","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"J Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher&apos;s disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"MJ Allen","year":"1997","journal-title":"Qjm"},{"key":"ref4","first-page":"205","article-title":"Cytokines in Gaucher&apos;s disease","volume":"10","author":"V Barak","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00223-001-2072-0","article-title":"Bone marker alterations in patients with type 1 Gaucher disease","volume":"72","author":"G Ciana","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00277-008-0441-8","article-title":"Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature","volume":"87","author":"M de Fost","year":"2008","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"CE Hollak","year":"1997","journal-title":"Blood Cells Mol Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"MJ van Breemen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"GM Pastores","year":"2004","journal-title":"Semin Hematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"NJ Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"MF Pittenger","year":"1999","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02256058","article-title":"Characterization and functionality of cell surface molecules on human mesenchymal stem cells","volume":"10","author":"MK Majumdar","year":"2003","journal-title":"J Biomed Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2010.08214.x","article-title":"Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease","volume":"150","author":"J Berger","year":"2010","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lecourt S, Vanneaux V, Cras A, Freida D, Heraoui D, <etal>et al<\/etal>.. (2011) Bone marrow microenvironment in an in vitro model of Gaucher Disease: consequences of Glucocerebrosidase deficiency. Stem Cells Dev.","DOI":"10.1089\/scd.2011.0365"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2009-02-205708","article-title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","volume":"114","author":"PM Campeau","year":"2009","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"PK Mistry","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood.V89.9.3412","article-title":"Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescence-activated cell sorter assay for lysosomal glucocerebrosidase activity","volume":"89","author":"M Lorincz","year":"1997","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1079-9796(03)00010-X","article-title":"Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease","volume":"30","author":"B Rudensky","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lecourt S, Vanneaux V, Leblanc T, Leroux G, Ternaux B, <etal>et al<\/etal>.. (2010) Bone marrow microenvironment in Fanconi Anemia: a prospective functional study in a cohort of Fanconi Anemia patients. Stem Cells Dev.","DOI":"10.1089\/scd.2009.0062"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"LD Shultz","year":"2005","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404466","article-title":"Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma","volume":"21","author":"B Arnulf","year":"2007","journal-title":"Leukemia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","article-title":"Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival","volume":"107","author":"DT Denhardt","year":"2001","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"E Conzelmann","year":"1983","journal-title":"Dev Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","article-title":"Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease","volume":"88","author":"P Leinekugel","year":"1992","journal-title":"Hum Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/B:BOLI.0000042959.44318.7c","article-title":"Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease","volume":"27","author":"UH Schueler","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1194\/jlr.M800092-JLR200","article-title":"Lipid composition of microdomains is altered in a cell model of Gaucher disease","volume":"49","author":"LK Hein","year":"2008","journal-title":"J Lipid Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20110153","article-title":"Vesicle trafficking and membrane remodelling in cytokinesis","volume":"437","author":"H Neto","year":"2011","journal-title":"Biochem J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2012.07.071","article-title":"Mucci JM, Scian R, De Francesco PN, Garcia FS, Ceci R, et al. Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-alpha","volume":"509","journal-title":"Gene"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1600-0609.2003.00047.x","article-title":"Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease \u2013 a histological study","volume":"70","author":"Z Rudzki","year":"2003","journal-title":"Eur J Haematol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"E Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma","volume":"42","author":"YW Qiang","year":"2008","journal-title":"Bone"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1210\/en.2005-0451","article-title":"Prostaglandin E2 strongly inhibits human osteoclast formation","volume":"146","author":"I Take","year":"2005","journal-title":"Endocrinology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"24035","DOI":"10.1074\/jbc.M500926200","article-title":"Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors","volume":"280","author":"Y Kobayashi","year":"2005","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"IB Enquist","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1634\/stemcells.2008-0844","article-title":"Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease","volume":"27","author":"IB Enquist","year":"2009","journal-title":"Stem Cells"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0069293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T11:25:51Z","timestamp":1715772351000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0069293"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Dardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0069293","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}